Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities

Journal of Medicinal Chemistry
2020.0

Abstract

Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappropriately located, it becomes toxic. Excess iron can become involved in free radical formation, resulting in oxidative stress and cellular damage. Iron chelators are used to treat serious pathological disorders associated with systemic iron overload. Hydroxypyridinones stand out for their outstanding chelation properties, including high selectivity for Fe in the biological environment, ease of derivatization, and good biocompatibility. Herein, we overview the potential for multifunctional hydroxypyridinone-based chelators to be used as therapeutic agents against a wide range of diseases associated either with systemic or local elevated iron levels.

Knowledge Graph

Similar Paper

Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities
Journal of Medicinal Chemistry 2020.0
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential
Journal of Medicinal Chemistry 1993.0
Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties and biological activity
Journal of Medicinal Chemistry 1990.0
Structure–Activity Relationships of Novel Iron Chelators for the Treatment of Iron Overload Disease: The Methyl Pyrazinylketone Isonicotinoyl Hydrazone Series
Journal of Medicinal Chemistry 2008.0
Copper Complexation by 3-Hydroxypyridin-4-one Iron Chelators: Structural and Iron Competition Studies
Journal of Medicinal Chemistry 1994.0
Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity
Journal of Medicinal Chemistry 2006.0
2-Acetylpyridine Thiosemicarbazones are Potent Iron Chelators and Antiproliferative Agents: Redox Activity, Iron Complexation and Characterization of their Antitumor Activity
Journal of Medicinal Chemistry 2009.0
Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators
Medicinal Chemistry Research 2013.0
A Novel Iron-Chelating Derivative of the Neuroprotective Peptide NAPVSIPQ Shows Superior Antioxidant and Antineurodegenerative Capabilities
Journal of Medicinal Chemistry 2008.0
Metabolically programmed iron chelators
Bioorganic & Medicinal Chemistry 2015.0